Low-Dose Ketamine Infusion During Burn Wound Care

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Tennessee

About this trial

The current standard of care (SOC) (i.e. fentanyl and midazolam) offers limited efficacy for preventing or relieving pain. Ketamine infusions may provide the benefits of analgesia, minimize adverse events, and reduce opioid use. The purpose of this study is to determine if adding a low dose ketamine infusion during wound care will safely provide pain relief for patients with burn injury.

Eligibility criteria

Qualifiers

Admitted to burn service with thermal injury

Disqualifiers

unable/unwilling to consent within 72 hours

unable to report NRS

known contraindication to ketamine

< than 18 years of age

Trial design

Treatments tested in this trial

  • Ketamine
  • 0.9% NaCl

Treatment groups

140 Participants
are divided into 2 treatment groups

Sponsors and collaborators